Evidence map›Paper›PMID 33452497›Full record

ArticleNature chemical biology2021

Publisher Correction: Rational discovery of molecular glue degraders via scalable chemical profiling.

Cristina Mayor-Ruiz, Sophie Bauer, Matthias Brand, Zuzanna Kozicka, Marton Siklos, Hana Imrichova, Ines H Kaltheuner, Elisa Hahn, Kristina Seiler, Anna Koren and 9 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Cristina Mayor-RuizCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Sophie Bauer *CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Matthias Brand *CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Zuzanna KozickaFMI Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Marton SiklosCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Hana ImrichovaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0003-0385-1823
Ines H KaltheunerInstitute of Structural Biology, University of Bonn, Bonn, Germany.
Elisa HahnCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0002-4064-1828
Kristina SeilerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Anna KorenCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0003-2528-4970
Georg PetzoldFMI Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Michaela FellnerResearch Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0001-6091-3088
André C MüllerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Johannes ZuberResearch Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.ORCID http://orcid.org/0000-0001-8810-6835
Matthias GeyerInstitute of Structural Biology, University of Bonn, Bonn, Germany.
Nicolas H ThomäFMI Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Stefan KubicekCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Georg E WinterCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. gwinter@cemm.oeaw.ac.at.ORCID http://orcid.org/0000-0001-6606-1437

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) P30271-B28Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) P32125-BEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) 796010EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 765445EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 851478European Molecular Biology Organization (EMBO) ALTF 761-849 2016Human Frontier Science Program (HFSP) LT000210/2014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.